Detalles de la búsqueda
1.
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.
Lancet Oncol
; 21(2): 271-282, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31838007
2.
Extended dosing with CC-486 (oral azacitidine) in patients with myeloid malignancies.
Am J Hematol
; 93(10): 1199-1206, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30016552
3.
An innovative, multi-arm, complete phase 1b study of the novel anti-cancer agent tasisulam in patients with advanced solid tumors.
Invest New Drugs
; 33(1): 148-58, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25260842
4.
Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy.
Cancer Immunol Immunother
; 63(8): 787-96, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24770667
5.
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas.
Oncologist
; 18(3): 271-2, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23485624
6.
Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy.
Adv Ther
; 40(10): 4189-4215, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37490258
7.
Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer.
Breast Cancer Res Treat
; 126(1): 101-8, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21188632
8.
Acute promyelocytic leukemia following solid organ transplantation.
Ann Hematol
; 95(1): 169-171, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26453075
9.
Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer.
J Clin Oncol
; 39(12): 1360-1370, 2021 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33513026
10.
A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma.
Cancer Chemother Pharmacol
; 87(1): 135-144, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33215270
11.
Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study.
Clin Cancer Res
; 27(12): 3360-3369, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33568344
12.
Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer.
Cancer Chemother Pharmacol
; 87(5): 689-700, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33595690
13.
Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer.
Clin Lung Cancer
; 21(5): 455-463.e4, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32586767
14.
Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study.
Lung Cancer
; 128: 105-112, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30642441
15.
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma.
Am J Clin Oncol
; 41(3): 230-235, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26709865
16.
A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2).
Clin Lymphoma Myeloma Leuk
; 17(7): 433-437, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28576443
17.
Results of a Phase II study of weekly docetaxel and carboplatin in Stage IIIB (with effusion) or Stage IV non-small cell lung cancer patients age
Lung Cancer
; 52(3): 313-7, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16621129
18.
Results of a phase II study of weekly paclitaxel plus carboplatin in patients with extensive small-cell lung cancer with Eastern Cooperative Oncology Group Performance Status of 2, or age > or = 70 years.
J Clin Oncol
; 22(10): 1872-7, 2004 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15143079
19.
(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies.
Eur J Cancer
; 51(14): 1857-64, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26187510
20.
A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors.
Cancer Chemother Pharmacol
; 74(5): 917-25, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25149088